IGM Biosciences
IGMS
IGMS was delisted on the 13th of August, 2025.
33 hedge funds and large institutions have $178M invested in IGM Biosciences in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
41.64% more ownership
Funds ownership: 0% → 41.64% (+42%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$63.5M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$63.5M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.5M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$10.6M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$9.41M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Norges Bank
Oslo,
Norway
| $178K | +$202K | +10,000 | New |
|
|
FCM
27
Flinton Capital Management
Philadelphia,
Pennsylvania
| $167K | +$190K | +9,392 | New |
|
|
PHK
28
Point72 Hong Kong
Hong Kong
| $123K | +$139K | +6,910 | New |
|
|
RCM
29
Riverhead Capital Management
Wilmington,
Delaware
| $110K | +$125K | +6,206 | New |
|
|
CSS
30
Cubist Systematic Strategies
Stamford,
Connecticut
| $94K | +$107K | +5,306 | New |
|
|
EIM
31
Essex Investment Management
Boston,
Massachusetts
| $89K | +$101K | +5,000 | New |
|
32
Morgan Stanley
New York
| $14K | +$15.5K | +769 | New |
|
|
CCA
33
Catalyst Capital Advisors
Huntington,
New York
| $4K | +$5.05K | +250 | New |
|
IGMS Hedge Fund Activity: Q3 2019 in Review
33 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in IGM Biosciences (IGMS) for Q3 2019, worth a combined $178M.
Buyers outnumbered sellers: 33 funds opened new IGMS positions and 0 closed out — a net gain of 33 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $63.5M.
- 33 institutional investors held IGM Biosciences (IGMS) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $178M of IGM Biosciences stock for Q3 2019.
- 33 funds opened new IGM Biosciences positions in Q3 2019 and 0 closed out, a net change of +33 holders.
- The largest IGM Biosciences buyer in Q3 2019 was Baker Bros. Advisors, an estimated $63.5M added.
Based on aggregated 13F filings for Q3 2019.